Which closed-end funds own Zyversa Therapeutics Inc?
2 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $3.9K. Security type: equity derivative. Country: United States. CUSIP 98987D110 · ISIN US98987D1101.
Holdings are historical filings (report dates Jun 30, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| RIV RiverNorth Opportunities Fund | Multi-Asset | 0.00% | $3.4K | 48,471 NC | $434M | 11.1% discount | Jun 30, 2026 |
| BRW Saba Capital Income & Opportunities Fund | U.S. Equity | 0.00% | $497 | 7,100 NC | $351M | 16.9% discount | Jul 31, 2026 |
2 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Issuer-level search for “Zyversa Therapeutics Inc” → · Compare two funds’ portfolios →